The urinalysis test market size valued for $3.19 Billion in 2021 and is estimated to reach $6.12 Billion by 2031, exhibiting a CAGR of 6.7% from 2022 to 2031.
A urinalysis is a common test that uses a urine sample to evaluate a wide variety of urine contents. Urinalysis is a test that examines the appearance, composition, and content of urine. It is a common diagnostic tool used to detect various health conditions such as urinary tract infections, kidney problems, liver problems, diabetes, and pregnancy. A urine sample is collected and sent to a laboratory for analysis during a urinalysis test. The sample is usually collected in a sterile container and obtained through a clean catch method, which involves collecting the midstream portion of urine, through a catheter.
The global urinalysis test market is majorly driven by an increase in the incidences of chronic diseases such as chronic kidney disease, urinary tract infections, and diabetes. For instance, according to Centers for Disease Control and Prevention (CDC), during July-December 2020, around 3.1% of adults aged 18 years had kidney disease. Chronic diseases such as diabetes, hypertension, and kidney diseases affect the urinary system, leading to changes in urine composition and color. As a result, urinalysis tests have become an essential diagnostic tool in the management of these chronic diseases. Therefore, the rise in prevalence of chronic diseases has increased the adoption of urinalysis tests to diagnose disease types, which propels the market growth.
In contrast, the limited awareness about the importance of urinalysis tests or lack of knowledge about collection of a urine sample, leading to inaccurate results impedes the growth of the market. In addition, many people in underdeveloped nations are not aware of the importance of urinalysis testing and do not understand the potential benefits of these tests, this could also limit the market growth.
Moreover, development and technological advancements in urinalysis testing provides growth opportunities in the emerging economies of Asia-Pacific and LAMEA regions during the forecast period. For instance, Mission U120 Urine Analyzer, a product of ACON Laboratories, Inc. company, has the capability of running up to 120 tests per hour and recalling 2,000 results. This enables a more accurate and comprehensive assessment of urine samples compared to traditional manual methods. Such technological advancements in urinalysis tests support the market growth.
In addition, there is a growing demand for point-of-care testing, which refers to diagnostic tests that can be performed near the patient's location. Urinalysis tests are often used as point-of-care tests, particularly in urgent care and emergency settings. The development of point-of-care urinalysis testing devices offers significant opportunities for growth and expansion of the urinalysis test market.
The global urinalysis test market is segmented into product, application, end user, and region. By product, the market is categorized into consumables and instruments. By application, the market is classified into disease screening and pregnancy & fertility. By end user, the market is classified into hospitals & clinics, diagnostic laboratories, and home care. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global urinalysis test market are Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., Bio-Rad Laboratories, Inc., Cardinal Health Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Sysmex Corporation, and 77 Elektronika Kft.
A urinalysis is a common test that uses a urine sample to evaluate a wide variety of urine contents. Urinalysis is a test that examines the appearance, composition, and content of urine. It is a common diagnostic tool used to detect various health conditions such as urinary tract infections, kidney problems, liver problems, diabetes, and pregnancy. A urine sample is collected and sent to a laboratory for analysis during a urinalysis test. The sample is usually collected in a sterile container and obtained through a clean catch method, which involves collecting the midstream portion of urine, through a catheter.
The global urinalysis test market is majorly driven by an increase in the incidences of chronic diseases such as chronic kidney disease, urinary tract infections, and diabetes. For instance, according to Centers for Disease Control and Prevention (CDC), during July-December 2020, around 3.1% of adults aged 18 years had kidney disease. Chronic diseases such as diabetes, hypertension, and kidney diseases affect the urinary system, leading to changes in urine composition and color. As a result, urinalysis tests have become an essential diagnostic tool in the management of these chronic diseases. Therefore, the rise in prevalence of chronic diseases has increased the adoption of urinalysis tests to diagnose disease types, which propels the market growth.
In contrast, the limited awareness about the importance of urinalysis tests or lack of knowledge about collection of a urine sample, leading to inaccurate results impedes the growth of the market. In addition, many people in underdeveloped nations are not aware of the importance of urinalysis testing and do not understand the potential benefits of these tests, this could also limit the market growth.
Moreover, development and technological advancements in urinalysis testing provides growth opportunities in the emerging economies of Asia-Pacific and LAMEA regions during the forecast period. For instance, Mission U120 Urine Analyzer, a product of ACON Laboratories, Inc. company, has the capability of running up to 120 tests per hour and recalling 2,000 results. This enables a more accurate and comprehensive assessment of urine samples compared to traditional manual methods. Such technological advancements in urinalysis tests support the market growth.
In addition, there is a growing demand for point-of-care testing, which refers to diagnostic tests that can be performed near the patient's location. Urinalysis tests are often used as point-of-care tests, particularly in urgent care and emergency settings. The development of point-of-care urinalysis testing devices offers significant opportunities for growth and expansion of the urinalysis test market.
The global urinalysis test market is segmented into product, application, end user, and region. By product, the market is categorized into consumables and instruments. By application, the market is classified into disease screening and pregnancy & fertility. By end user, the market is classified into hospitals & clinics, diagnostic laboratories, and home care. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global urinalysis test market are Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., Bio-Rad Laboratories, Inc., Cardinal Health Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Sysmex Corporation, and 77 Elektronika Kft.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the urinalysis test market analysis from 2021 to 2031 to identify the prevailing urinalysis test market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the urinalysis test market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global urinalysis test market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Instruments
- Consumables
- Disease screening
- Pregnancy and fertility
By End user
- Hospitals and clinics
- Diagnostic laboratories
- Home care
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Cardinal Health Inc.
- Siemens AG
- 77 Elektronika Kft
- ACON Laboratories, Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- ARKRAY, Inc.
- Abbott Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: URINALYSIS TEST MARKET, BY PRODUCT
CHAPTER 5: URINALYSIS TEST MARKET, BY APPLICATION
CHAPTER 6: URINALYSIS TEST MARKET, BY END USER
CHAPTER 7: URINALYSIS TEST MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Cardinal Health Inc.
- Siemens AG
- 77 Elektronika Kft
- ACON Laboratories, Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- ARKRAY, Inc.
- Abbott Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
